July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
December 2025
The global drug formulation market size is calculated at USD 1.96 trillion in 2025 and is projected to hit around USD 3.50 trillion by 2035 with a CAGR of 5.97%.
August 2025
The global general anesthesia drugs market size was calculated at USD 5.40 billion in 2024 and is projected to surpass around USD 7.79 billion by 2034, with a CAGR of 3.73%.
August 2025
The global rifaximin market size was estimated at USD 1.84 billion in 2024 and is projected to hit around USD 5.09 billion by 2034, with a notable CAGR of 10.72%.
August 2025
The global non-sterile liquids and suspensions market size was evaluated at USD 48.06 million in 2024 and is predicted to hit around USD 95.25 million by 2034, growing at a CAGR of 7.08%.
July 2026
The global pharmacovigilance and drug safety software market size was evaluated at USD 2.09 billion in 2025 and is predicted to hit around USD 5.06 billion by 2035, growing at a CAGR of 9.24%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The advanced technologies in marine drug development market accelerates drug discovery with advanced tech and deep-sea pharmaceutical potential.
July 2026
The AI-powered industrial drones market expands with applications in energy, agriculture, and construction, enhancing productivity through AI integration.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2026
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
July 2026
The global AI-powered edge robotics market is growing as industries adopt intelligent robots with edge computing for real-time decision-making.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
June 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global sarcoidosis drug market size was estimated at USD 8.82 billion in 2025 and is expected to hit around USD 15.93 billion by 2035, growing at a CAGR of 6.09%.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com